Signe Regner Michaelsen
Postdoc
Kristensen Group
Ole Maaløes Vej 5
2200 København N.
- 2023
- Published
Differential expression of checkpoint markers in the normoxic and hypoxic microenvironment of glioblastomas
Petterson, S. A., Sørensen, M. D., Burton, M., Thomassen, M., Kruse, T. A., Michaelsen, Signe Regner & Kristensen, Bjarne Winther, 2023, In: Brain Pathology. 33, 1, 14 p., e13111.Research output: Contribution to journal › Journal article › Research › peer-review
- 2022
- Published
Surgical resection of glioblastomas induces pleiotrophin-mediated self-renewal of glioblastoma stem cells in recurrent tumors
Knudsen, A. M., Halle, B., Cédile, O., Burton, M., Baun, C., Thisgaard, H., Anand, Atul, Hubert, C., Thomassen, M., Michaelsen, Signe Regner, Olsen, B. B., Dahlrot, R. H., Bjerkvig, R., Lathia, J. D. & Kristensen, Bjarne Winther, 2022, In: Neuro-Oncology. 24, 7, p. 1074-1087 14 p.Research output: Contribution to journal › Journal article › Research › peer-review
- 2021
- Published
A Prognostic Model for Glioblastoma Patients Treated With Standard Therapy Based on a Prospective Cohort of Consecutive Non-Selected Patients From a Single Institution
Abedi, A. A., Grunnet, K., Christensen, I. J., Michaelsen, Signe Regner, Muhic, A., Møller, Søren, Hasselbalch, B., Poulsen, H. S. & Urup, T., 2021, In: Frontiers in Oncology. 11, 597587.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Drug Repurposing Screen Reveals Glioblastoma Cell Line Susceptibility to Statins
Harwood, Dylan Scott Lykke, Michaelsen, Signe Regner, Mundt, F. & Kristensen, Bjarne Winther, 2021, In: Neuro-Oncology. 23, S6, p. 77-78 2 p.Research output: Contribution to journal › Conference abstract in journal › Research
- 2020
- Published
Angiotensinogen promoter methylation predicts bevacizumab treatment response of patients with recurrent glioblastoma
Urup, T., Gillberg, Linn, Kaastrup, K., Lü, M. J. S., Michaelsen, Signe Regner, Andrée Larsen, V., Christensen, I. J., Broholm, H., Lassen, Ulrik Niels, Grønbæk, Kirsten & Poulsen, H. S., 2020, In: Molecular Oncology. 14, 5, p. 964-973Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Genomic profiling of newly diagnosed glioblastoma patients and its potential for clinical utility – a prospective, translational study
Nørøxe, D. S., Yde, C. W., Østrup, O., Michaelsen, Signe Regner, Schmidt, A. Y., Kinalis, S., Torp, M. H., Skjøth‐Rasmussen, J., Brennum, J., Hamerlik, P., Poulsen, H. S., Nielsen, Finn Cilius & Lassen, Ulrik Niels, 2020, In: Molecular Oncology.Research output: Contribution to journal › Journal article › Research › peer-review
- 2019
- Published
VEGF-C as a putative therapeutic target in cancer
Michaelsen, Signe Regner, Poulsen, H. S. & Hamerlik, P., 18 Jun 2019, In: OncoTarget. 10, 40, p. 3988-3990 3 p.Research output: Contribution to journal › Editorial › Research › peer-review
- Published
Angiotensinogen promoter methylation to predict bevacizumab response in recurrent glioblastoma patients
Urup, T., Gillberg, Linn, Kaastrup, K., Lu, M. S., Michaelsen, Signe Regner, Larsen, V. A., Christensen, I. J., Broholm, H., Lassen, Ulrik Niels, Grønbæk, Kirsten & Poulsen, H. S., 2019, In: Neuro-Oncology. 21, Supplement 6, p. vi149Research output: Contribution to journal › Conference abstract in journal › Research › peer-review
- Published
Cell-free DNA in newly diagnosed patients with glioblastoma - a clinical prospective feasibility study
Nørøxe, D. S., Østrup, O., Yde, C. W., Ahlborn, L. B., Nielsen, Finn Cilius, Michaelsen, Signe Regner, Larsen, V. A., Skjøth-Rasmussen, J., Brennum, J., Hamerlik, P., Poulsen, H. S. & Lassen, Ulrik Niels, 2019, In: OncoTarget. 10, 43, p. 4397-4406 10 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Clinical Characteristics of Gliosarcoma and Outcomes From Standardized Treatment Relative to Conventional Glioblastoma
Frandsen, S., Broholm, H., Larsen, V. A., Grunnet, K., Moller, S., Poulsen, H. S. & Michaelsen, Signe Regner, 2019, In: Frontiers in Oncology. 9, p. 1-11 01425.Research output: Contribution to journal › Journal article › Research › peer-review
ID: 108812376
Most downloads
-
174
downloads
Angiotensinogen and HLA class II predict bevacizumab response in recurrent glioblastoma patients
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
101
downloads
Transcriptional changes induced by bevacizumab combination therapy in responding and non-responding recurrent glioblastoma patients
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
93
downloads
Targeting glioma stem-like cell survival and chemoresistance through inhibition of lysine-specific histone demethylase KDM2B
Research output: Contribution to journal › Journal article › Research › peer-review
Published